Arab Finance: GlaxoSmithKline’s (GSK-Egypt) ordinary general meeting (OGM) has decided to distribute cash dividends of EGP 0.75 per share to shareholders for 2023 on July 22nd, according to a statement on July 17th.
The eligibility in dividend distribution to shareholders will be on a record date of July 17th.
GSK Egypt, a member of the British pharmaceutical company Glaxo Group, is an Egypt-based company engaged in the manufacturing, packaging, marketing, selling, and distribution of pharmaceutical products.